J.P. Morgan Healthcare Conference
Medical device company Stryker (NYSE:SYK) will put a renewed focus on efforts to boost sales in markets outside of the U.S., president & CEO Kevin Lobo told an audience at the J.P. Morgan Healthcare Conference in San Francisco Wednesday.
Those efforts include an overhaul of Stryker’s European business and a growing push in emerging markets, Lobo said.
Medical device company NuVasive (NSDQ:NUVA) got a big boost this morning after releasing preliminary results for 2012, with a jocular chairman & CEO Alex Lukianov sharing some of the highlights with an audience at the J.P. Morgan healthcare conference in San Francisco.
NuVasive beat its own estimates for 2012 with full-year revenues of about $619 million, compared to previous guidance of $601-$606 million for the year.
When MassDevice.com last spoke with Omar Ishrak, the CEO of the world’s largest pure-play medical device company, he detailed a trio of goals for Medtronic (NYSE:MDT) designed to remake the company after his own image: Better execution, optimized innovation and a larger share of the global medtech business.